Tidepath

Cognition peptides

Semax

A short peptide built on a piece of a stress hormone, with doses in its registered instructions but thin evidence as a nootropic, for memory and focus.

Status
Registered as a medicine in Russia, where it's dispensed only on prescription; not approved by the FDA.
How it's taken
In the nose
Where doses come from
Registered product instructions
Half-life
No measured half-life in people in our sources

What it is

Semax is a heptapeptide, a chain of seven amino acids, based on ACTH(4-10), a short piece of a stress hormone, adrenocorticotropic hormone. It keeps the first four amino acids of that piece and swaps the other three for a tail that helps it resist breakdown. It's registered as a medicine in Russia as nasal drops, dispensed there only on prescription: a weaker solution for brain and nerve conditions, including problems with thinking, and a stronger one for the early stage of a moderate or severe stroke caused by a blocked blood vessel. It isn't FDA-approved.

What makes it distinct

Its doses come from the registered instructions for its nasal drops, not community practice. That makes Semax a clear example of a difference: a dose with a clear source and good evidence that a drug works are two different things. Semax has the first without the second.

Open questions

  • Whether the effects on thinking reported in Russian practice hold up when tested by a group with no stake in the result. The 1997 summary and both brain-scan studies with placebo groups all share an author with Semax's developers. The brain-scan studies measured how brain areas connect at rest, not memory or focus, and the Alzheimer's Drug Discovery Foundation found little evidence it helps thinking in healthy people.
  • How long it lasts in the body (pharmacokinetics). Its registered instructions give no half-life (the time it takes for half a dose to clear), and we found none measured in people. Tidepath doesn't chart its levels.
  • Safety with repeated use. The Alzheimer's Drug Discovery Foundation notes there's little evidence on this in people.
  • What an injected dose means. The doses in its registered instructions are nasal, and nothing in our sources establishes the matching amount for an injection under the skin.

Worth knowing

The FDA says compounded Semax (mixed from its ingredients by a pharmacist or doctor) given certain ways may carry a risk of immune reactions (immunogenicity), because of the potential for the peptide to clump together (aggregation) and for impurities related to it. It also says it has little or no safety information for the routes proposed for it. That's about compounded products, not the nasal drops registered in Russia.

More in Cognition peptides